Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-week Results of AIDS Clinical Trials Group A5241 (OPTIONS).

Gandhi RT, Tashima KT, Smeaton LM, Vu V, Ritz J, Andrade A, Eron JJ, Hogg E, Fichtenbaum CJ; ACTG A5241 study team.

J Infect Dis. 2019 May 28. pii: jiz281. doi: 10.1093/infdis/jiz281. [Epub ahead of print]

PMID:
31135883
2.

Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.

Wehrenberg-Klee E, Gandhi RT, Ganguli S.

Tech Vasc Interv Radiol. 2019 Jun;22(2):70-73. doi: 10.1053/j.tvir.2019.02.006. Epub 2019 Feb 27. Review.

PMID:
31079713
3.

Management of High Hepatopulmonary Shunts in the Setting of Y90 Radioembolization.

Schiro BJ, Amour ES, Harnain C, Gandhi RT.

Tech Vasc Interv Radiol. 2019 Jun;22(2):58-62. doi: 10.1053/j.tvir.2019.02.004. Epub 2019 Feb 27.

PMID:
31079711
4.

Introduction to Issue on Yttrium-90 Radioembolization.

Gandhi RT.

Tech Vasc Interv Radiol. 2019 Jun;22(2):41. doi: 10.1053/j.tvir.2019.02.001. Epub 2019 Feb 28. No abstract available.

PMID:
31079708
5.

Early clinical experience with a touchless image navigation interface for the endovascular suite.

Homayoon B, Chung J, Gandhi RT, Liu DM.

Minim Invasive Ther Allied Technol. 2019 May 8:1-8. doi: 10.1080/13645706.2019.1612440. [Epub ahead of print]

PMID:
31066595
6.

HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated with HIV DNA and HIV-specific T Cell Responses.

Keating SM, Jones RB, Lalama CM, Bosch RJ, McMahon D, Hampton D, Cyktor J, Eron JJ, Mellors JW, Busch MP, Gandhi RT; and the ACTG 5321 team.

J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002080. [Epub ahead of print]

PMID:
31045647
7.

Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.

Wojciechowski D, Gandhi RT, Rosales IA.

N Engl J Med. 2019 Apr 11;380(15):1464-1472. doi: 10.1056/NEJMcpc1900417. No abstract available.

PMID:
30970193
8.

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.

Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, Colby DJ, Dawson L, Dong KL, Dubé K, Eron J, Frater J, Gandhi RT, Geleziunas R, Goulder P, Hanna GJ, Jefferys R, Johnston R, Kuritzkes D, Li JZ, Likhitwonnawut U, van Lunzen J, Martinez-Picado J, Miller V, Montaner LJ, Nixon DF, Palm D, Pantaleo G, Peay H, Persaud D, Salzwedel J, Salzwedel K, Schacker T, Sheikh V, Søgaard OS, Spudich S, Stephenson K, Sugarman J, Taylor J, Tebas P, Tiemessen CT, Tressler R, Weiss CD, Zheng L, Robb ML, Michael NL, Mellors JW, Deeks SG, Walker BD.

Lancet HIV. 2019 Apr;6(4):e259-e268. doi: 10.1016/S2352-3018(19)30052-9. Epub 2019 Mar 15. Review.

PMID:
30885693
9.

Targeting the third '90': introducing the viral load champion.

Sunpath H, Hatlen TJ, Naidu KK, Msimango P, Adams RN, Moosa MS, Marconi VC, Murphy RA, Gandhi RT, Pillay S, Siedner M, Naidoo K.

Public Health Action. 2018 Dec 21;8(4):225-231. doi: 10.5588/pha.18.0063.

10.

Step-by-Step Approach to Management of Type II Endoleaks.

Bryce Y, Lam CK, Ganguli S, Schiro BJ, Cooper K, Cline M, Oklu R, Vatakencherry G, Peña CS, Gandhi RT.

Tech Vasc Interv Radiol. 2018 Sep;21(3):188-195. doi: 10.1053/j.tvir.2018.06.009. Epub 2018 Jun 14. Review.

PMID:
30497554
11.

HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study.

Jilg N, Hunt PW, Gandhi RT.

AIDS. 2018 Sep 24;32(15):2255-2257. doi: 10.1097/QAD.0000000000001949. No abstract available.

12.

Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex.

Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E.

Int J Syst Evol Microbiol. 2018 Nov;68(11):3557-3562. doi: 10.1099/ijsem.0.003031. Epub 2018 Sep 11.

PMID:
30204586
13.

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.

Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ.

J Infect Dis. 2018 Nov 5;218(12):1954-1963. doi: 10.1093/infdis/jiy479.

PMID:
30085241
14.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ Jr, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA.

JAMA. 2018 Jul 24;320(4):379-396. doi: 10.1001/jama.2018.8431.

PMID:
30043070
15.

HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.

Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ.

J Clin Invest. 2018 Aug 31;128(9):4074-4085. doi: 10.1172/JCI120549. Epub 2018 Aug 20.

16.

Endovascular management of iliac aneurysmal disease with hypogastric artery preservation.

Schiro BJ, Gandhi RT, Peña CS, Geronemus AR, Powell A, Benenati JF.

Cardiovasc Diagn Ther. 2018 Apr;8(Suppl 1):S168-S174. doi: 10.21037/cdt.2017.09.05. Review.

17.

Type II endoleaks: diagnosis and treatment algorithm.

Bryce Y, Schiro B, Cooper K, Ganguli S, Khayat M, Lam CK, Oklu R, Vatakencherry G, Gandhi RT.

Cardiovasc Diagn Ther. 2018 Apr;8(Suppl 1):S131-S137. doi: 10.21037/cdt.2017.08.06. Review.

18.

Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.

Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ.

J Virol. 2018 May 29;92(12). pii: e00285-18. doi: 10.1128/JVI.00285-18. Print 2018 Jun 15.

19.

Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.

Ard KL, Kelly HR, Gandhi RT, Louissaint A Jr.

N Engl J Med. 2018 Mar 22;378(12):1143-1152. doi: 10.1056/NEJMcpc1800321. No abstract available.

PMID:
29562158
20.

Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.

Gandhi M, Gandhi RT, Stefanescu A, Bosch RJ, Cyktor JC, Horng H, Louie A, Phung N, Eron JJ, Hogg E, Macatangay BJC, Hensel C, Fletcher CV, Mellors JW, McMahon DK; A5321 Team.

J Infect Dis. 2018 Jun 20;218(2):234-238. doi: 10.1093/infdis/jiy011.

21.

Colorectal Liver Metastasis: Overview of Treatment Paradigm Highlighting the Role of Ablation.

Venkat SR, Mohan PP, Gandhi RT.

AJR Am J Roentgenol. 2018 Apr;210(4):883-890. doi: 10.2214/AJR.17.18574. Epub 2018 Feb 15. Review.

PMID:
29446675
22.

Can thrombus age guide thrombolytic therapy?

Czaplicki C, Albadawi H, Partovi S, Gandhi RT, Quencer K, Deipolyi AR, Oklu R.

Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S186-S196. doi: 10.21037/cdt.2017.11.05. Review.

23.

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption.

Park YJ, Etemad B, Ahmed H, Naranbhai V, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Para M, Gandhi RT, Carrington M, Li JZ.

Pathog Immun. 2017;2(3):431-445. doi: 10.20411/pai.v2i3.222. Epub 2017 Nov 27.

24.

Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.

Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD.

Vaccine. 2018 Jan 25;36(4):453-460. doi: 10.1016/j.vaccine.2017.12.018. Epub 2017 Dec 16.

25.

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.

Thomas AS, Jones KL, Gandhi RT, McMahon DK, Cyktor JC, Chan D, Huang SH, Truong R, Bosque A, Macedo AB, Kovacs C, Benko E, Eron JJ, Bosch RJ, Lalama CM, Simmens S, Walker BD, Mellors JW, Jones RB.

PLoS Pathog. 2017 Sep 20;13(9):e1006629. doi: 10.1371/journal.ppat.1006629. eCollection 2017 Sep.

26.

Incident of Stroke after Transradial Arterial Access for Subdiaphragmatic Intervention.

Al-Hakim R, Gandhi RT, Benenati JF.

J Vasc Interv Radiol. 2017 Sep;28(9):1287-1288. doi: 10.1016/j.jvir.2017.05.012. No abstract available.

PMID:
28841936
27.

Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR.

J Infect Dis. 2017 Jul 15;216(2):254-262. doi: 10.1093/infdis/jix265.

28.

The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.

Siedner MJ, Bwana MB, Moosa MS, Paul M, Pillay S, McCluskey S, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson B, Gandhi RT, Sunpath H, Marconi VC.

HIV Clin Trials. 2017 Jul;18(4):149-155. doi: 10.1080/15284336.2017.1349028. Epub 2017 Jul 18. Review.

29.

Case 20-2017 - A 48-Year-Old Man with Weight Loss, Confusion, Skin Lesions, and Pancytopenia.

Mukerji SS, Gonzalez RG, Gandhi RT, Kraft S.

N Engl J Med. 2017 Jun 29;376(26):2580-2589. doi: 10.1056/NEJMcpc1616401. No abstract available.

PMID:
28657866
30.

Ovarian Endometrioma Superinfected With Salmonella: Case Report and Review of the Literature.

Adelman MW, Johnson JH, Hohmann EL, Gandhi RT.

Open Forum Infect Dis. 2017 Apr 17;4(2):ofx048. doi: 10.1093/ofid/ofx048. eCollection 2017 Spring.

31.

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.

Gandhi RT, McMahon DK, Bosch RJ, Lalama CM, Cyktor JC, Macatangay BJ, Rinaldo CR, Riddler SA, Hogg E, Godfrey C, Collier AC, Eron JJ, Mellors JW; ACTG A5321 Team.

PLoS Pathog. 2017 Apr 20;13(4):e1006285. doi: 10.1371/journal.ppat.1006285. eCollection 2017 Apr.

32.

Effect of β-blocker on aneurysm sac behavior after endovascular abdominal aortic repair.

Kim W, Gandhi RT, Peña CS, Herrera RE, Schernthaner MB, Tsoukas A, Acuña JM, Katzen BT.

J Vasc Surg. 2017 Feb;65(2):337-345. doi: 10.1016/j.jvs.2016.06.111.

33.

Influence of Statin Therapy on Aneurysm Sac Regression after Endovascular Aortic Repair.

Kim W, Gandhi RT, Peña CS, Herrera RE, Schernthaner MB, Acuña JM, Becerra VN, Katzen BT.

J Vasc Interv Radiol. 2017 Jan;28(1):35-43. doi: 10.1016/j.jvir.2016.09.010. Epub 2016 Nov 16.

PMID:
27865577
34.

The Influence of Statin Therapy on Restenosis in Patients Who Underwent Nitinol Stent Implantation for de Novo Femoropopliteal Artery Disease: Two-Year Follow-up at a Single Center.

Kim W, Gandhi RT, Peña CS, Herrera RE, Schernthaner MB, Acuña JM, Becerra VN, Katzen BT.

J Vasc Interv Radiol. 2016 Oct;27(10):1494-501. doi: 10.1016/j.jvir.2016.05.037. Epub 2016 Aug 10.

PMID:
27522274
35.

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA.

JAMA. 2016 Jul 12;316(2):191-210. doi: 10.1001/jama.2016.8900.

36.

Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.

Treasure GC, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Para M, Gandhi RT, Li JZ.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):310-3. doi: 10.1097/QAI.0000000000000964.

37.

HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.

Tashima KT, Smeaton LM, Fichtenbaum CJ, Andrade A, Eron JJ, Gandhi RT, Johnson VA, Klingman KL, Ritz J, Hodder S, Santana JL, Wilkin T, Haubrich RH; A5241 Study Team.

Ann Intern Med. 2015 Dec 15;163(12):908-17. doi: 10.7326/M15-0949. Epub 2015 Nov 24.

38.

The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.

Li JZ, Etemad B, Ahmed H, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Lederman MM, Para M, Gandhi RT.

AIDS. 2016 Jan 28;30(3):343-53. doi: 10.1097/QAD.0000000000000953. Erratum in: AIDS. 2016 Sep 10;30(14):2259.

39.

Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.

Kearney MF, Wiegand A, Shao W, Coffin JM, Mellors JW, Lederman M, Gandhi RT, Keele BF, Li JZ.

J Virol. 2015 Nov 18;90(3):1369-76. doi: 10.1128/JVI.02139-15. Print 2016 Feb 1.

40.

Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.

Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW.

AIDS. 2015 Oct 23;29(16):2121-9. doi: 10.1097/QAD.0000000000000810.

41.

HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection.

Gandhi RT, Bosch RJ, Rangsin R, Chuenchitra T, Sirisopana N, Kim JH, Robb ML, Vejbaesya S, Paris RM, Nelson KE.

AIDS Res Hum Retroviruses. 2016 Jan;32(1):44-9. doi: 10.1089/aid.2015.0120. Epub 2015 Sep 18.

42.

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir.

Ouyang Z, Buzon MJ, Zheng L, Sun H, Yu XG, Bosch RJ, Mellors JW, Eron JJ, Gandhi RT, Lichterfeld M.

Open Forum Infect Dis. 2015 Apr 1;2(2):ofv045. doi: 10.1093/ofid/ofv045. eCollection 2015 Apr.

43.

Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.

Gandhi RT, Kwon DS, Macklin EA, Shopis JR, McLean AP, McBrine N, Flynn T, Peter L, Sbrolla A, Kaufmann DE, Porichis F, Walker BD, Bhardwaj N, Barouch DH, Kavanagh DG.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):246-53. doi: 10.1097/QAI.0000000000000852.

44.

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

Riddler SA, Aga E, Bosch RJ, Bastow B, Bedison M, Vagratian D, Vaida F, Eron JJ, Gandhi RT, Mellors JW; ACTG A5276s Protocol Team.

J Infect Dis. 2016 Feb 15;213(4):556-60. doi: 10.1093/infdis/jiv433. Epub 2015 Sep 2.

45.

Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.

Tashima KT, Mollan KR, Na L, Gandhi RT, Klingman KL, Fichtenbaum CJ, Andrade A, Johnson VA, Eron JJ, Smeaton L, Haubrich RH.

HIV Clin Trials. 2015 Aug;16(4):147-56. doi: 10.1179/1945577115Y.0000000001. Epub 2015 Jul 27.

46.

Percutaneous Large Arterial Access Closure Techniques.

McGraw CJ, Gandhi RT, Vatakencherry G, Baumann F, Benenati JF.

Tech Vasc Interv Radiol. 2015 Jun;18(2):122-6. doi: 10.1053/j.tvir.2015.04.010. Epub 2015 Apr 11.

PMID:
26070624
47.

Technical Approach to Antegrade Femoral Access.

Wagner J, Gandhi RT, Powell A.

Tech Vasc Interv Radiol. 2015 Jun;18(2):82-6. doi: 10.1053/j.tvir.2015.04.005. Epub 2015 Apr 11. Erratum in: Tech Vasc Interv Radiol. 2015 Dec;18(4):285. Wager, Jaime [Corrected to Wagner, Jaime].

PMID:
26070619
48.

Introduction.

Gandhi RT, Vatakencherry G.

Tech Vasc Interv Radiol. 2015 Jun;18(2):57. doi: 10.1053/j.tvir.2015.04.001. Epub 2015 Apr 10. No abstract available.

PMID:
26070615
49.

Reliability and accuracy of simple visual estimation in assessment of peripheral arterial stenosis.

Rajebi MR, Benenati MJ, Schernthaner MB, Walker G, Gandhi RT, Pena CS, Katzen BT.

J Vasc Interv Radiol. 2015 Jun;26(6):890-6. doi: 10.1016/j.jvir.2015.02.018. Epub 2015 Apr 3.

PMID:
25847148
50.

A Case of Septic Arthritis of the Shoulder Due to Yersinia enterocolitica with Review of the Literature.

Chan J, Gandhi RT.

Open Forum Infect Dis. 2014 Aug 2;1(2):ofu054. doi: 10.1093/ofid/ofu054. eCollection 2014 Sep.

Supplemental Content

Loading ...
Support Center